| scholarly article | Q13442814 |
| P50 | author | Neerupma Silswal | Q59707666 |
| P2093 | author name string | Nilofer Qureshi | |
| Asaf A Qureshi | |||
| Nidhi S Reddy | |||
| P2860 | cites work | LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF | Q24672442 |
| The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 | ||
| The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events | Q28594630 | ||
| Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? | Q34214158 | ||
| Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials | Q34415123 | ||
| Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span | Q34820212 | ||
| Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models | Q35505150 | ||
| CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance | Q35845957 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| Proteasome protease mediated regulation of cytokine induction and inflammation | Q36301130 | ||
| Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma | Q36384889 | ||
| Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry | Q36433739 | ||
| Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers | Q36502078 | ||
| 20S proteasome and its inhibitors: crystallographic knowledge for drug development | Q36742369 | ||
| Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications | Q36979669 | ||
| A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model | Q37151518 | ||
| Nutritional Supplement-5 with a Combination of Proteasome Inhibitors (Resveratrol, Quercetin, δ-Tocotrienol) Modulate Age-Associated Biomarkers and Cardiovascular Lipid Parameters in Human Subjects | Q37364057 | ||
| Endotoxin tolerance: new mechanisms, molecules and clinical significance | Q37603612 | ||
| Small molecule SIRT1 activators for the treatment of aging and age-related diseases | Q37673310 | ||
| Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease | Q37831940 | ||
| Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development | Q38019864 | ||
| The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer | Q38087182 | ||
| Sepsis Up-Regulates CD14 Expression in a MyD88 Dependent and Trif Independent Pathway | Q38754037 | ||
| Resveratrol reduces the proinflammatory effects and lipopolysaccharide- induced expression of HMGB1 and TLR4 in RAW264.7 cells | Q38997831 | ||
| Impact of wines and wine constituents on cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase catalytic activity. | Q39153607 | ||
| Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress | Q42709995 | ||
| PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo | Q42821645 | ||
| Sepsis: redox mechanisms and therapeutic opportunities | Q43203144 | ||
| A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. | Q45969598 | ||
| Resveratrol reduces renal and lung injury caused by sepsis in rats | Q46952282 | ||
| Of Mice and Men: Proteasome's Role in LPS-Induced Inflammation and Tolerance. | Q53720678 | ||
| Key inflammatory signaling pathways are regulated by the proteasome | Q83298977 | ||
| Human monocytes produce interferon-gamma upon stimulation with LPS | Q87552501 | ||
| P921 | main subject | sepsis | Q183134 |
| biomarker | Q864574 | ||
| P577 | publication date | 2017-12-13 | |
| P1433 | published in | Shock | Q7499831 |
| P1476 | title | Resveratrol Downregulates Biomarkers of Sepsis via Inhibition of Proteasome's Proteases |
| Q64078780 | Challenge to the Intestinal Mucosa During Sepsis | cites work | P2860 |
Search more.